Paper35968331
CDC20 is a novel biomarker for improved clinical predictions in epithelial ovarian cancer.
Xi X and 9 others. Am J Cancer Res, 2022. Cited by 16 papers, by iCite.
Cite this record
ConductScience Library. CDC20 is a novel biomarker for improved clinical predictions in epithelial ovarian cancer. Papers, record 35968331. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/35968331
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- CDC20 is a novel biomarker for improved clinical predictions in epithelial ovarian cancer.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References53
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 31921802 | Integrative Bioinformatics Approaches to Map Potential Novel Genes and Pathways Involved in Ovarian Cancer. | Front Bioeng Biotechnol | 2019 | https://conductscience.org/library/papers/31921802 | PubMed |
| 2 | 31412296 | SOX2 in development and cancer biology. | Semin Cancer Biol | 2020 | https://conductscience.org/library/papers/31412296 | PubMed |
| 3 | 33907851 | CDC20 promotes the progression of hepatocellular carcinoma by regulating epithelial‑mesenchymal transition. | Mol Med Rep | 2021 | https://conductscience.org/library/papers/33907851 | PubMed |
| 4 | 24871945 | APC(Cdc20) suppresses apoptosis through targeting Bim for ubiquitination and destruction. | Dev Cell | 2014 | https://conductscience.org/library/papers/24871945 | PubMed |
| 5 | 34253236 | Integrative analysis of key candidate genes and signaling pathways in ovarian cancer by bioinformatics. | J Ovarian Res | 2021 | https://conductscience.org/library/papers/34253236 | PubMed |
| 6 | 32453965 | Transcriptional information underlying the generation of CSCs and the construction of a nine-mRNA signature to improve prognosis prediction in colorectal cancer. | Cancer Biol Ther | 2020 | https://conductscience.org/library/papers/32453965 | PubMed |
| 7 | 33800113 | New Predictive Biomarkers for Ovarian Cancer. | Diagnostics (Basel) | 2021 | https://conductscience.org/library/papers/33800113 | PubMed |
| 8 | 30593179 | CDC20 overexpression leads to poor prognosis in solid tumors: A system review and meta-analysis. | Medicine (Baltimore) | 2018 | https://conductscience.org/library/papers/30593179 | PubMed |
| 9 | 30816486 | CDC20 contributes to the development of human cutaneous squamous cell carcinoma through the Wnt/β‑catenin signaling pathway. | Int J Oncol | 2019 | https://conductscience.org/library/papers/30816486 | PubMed |
| 10 | 32130708 | Ovarian Cancer Biomarkers: Moving Forward in Early Detection. | Adv Exp Med Biol | 2020 | https://conductscience.org/library/papers/32130708 | PubMed |
| 11 | 35245004 | Major clinical research advances in gynecologic cancer in 2021. | J Gynecol Oncol | 2022 | https://conductscience.org/library/papers/35245004 | PubMed |
| 12 | 32165320 | APC/C ubiquitin ligase: Functions and mechanisms in tumorigenesis. | Semin Cancer Biol | 2020 | https://conductscience.org/library/papers/32165320 | PubMed |
| 13 | 26438599 | Cotargeting Polo-Like Kinase 1 and the Wnt/β-Catenin Signaling Pathway in Castration-Resistant Prostate Cancer. | Mol Cell Biol | 2015 | https://conductscience.org/library/papers/26438599 | PubMed |
| 14 | 30904606 | Cell division cycle 20 (CDC20) drives prostate cancer progression via stabilization of β-catenin in cancer stem-like cells. | EBioMedicine | 2019 | https://conductscience.org/library/papers/30904606 | PubMed |
| 15 | 35405118 | Experimental models for ovarian cancer research. | Exp Cell Res | 2022 | https://conductscience.org/library/papers/35405118 | PubMed |
| 16 | 33290869 | Cdc20 induces the radioresistance of bladder cancer cells by targeting FoxO1 degradation. | Cancer Lett | 2021 | https://conductscience.org/library/papers/33290869 | PubMed |
| 17 | 22488197 | Overexpression of CDC20 predicts poor prognosis in primary non-small cell lung cancer patients. | J Surg Oncol | 2012 | https://conductscience.org/library/papers/22488197 | PubMed |
| 18 | 30222931 | Additive Polyplexes to Undertake siRNA Therapy against CDC20 and Survivin in Breast Cancer Cells. | Biomacromolecules | 2018 | https://conductscience.org/library/papers/30222931 | PubMed |
| 19 | 34064635 | Therapeutic Strategies for Targeting Ovarian Cancer Stem Cells. | Int J Mol Sci | 2021 | https://conductscience.org/library/papers/34064635 | PubMed |
| 20 | 31636669 | Diverse Effects of Lysophosphatidic Acid Receptors on Ovarian Cancer Signaling Pathways. | J Oncol | 2019 | https://conductscience.org/library/papers/31636669 | PubMed |
Cited by11
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 16 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41029491 | A signature of correlated CDC20 and UBCH10 expression indicates poor prognosis in primary head and neck squamous cell carcinoma. | BMC Cancer | 2025 | https://conductscience.org/library/papers/41029491 | PubMed |
| 40579133 | [CRISPR-Cas9-mediated CDC20 gene knockout inhibits cervical cancer cell proliferation, invasion and metastasis]. | Nan Fang Yi Ke Da Xue Xue Bao | 2025 | https://conductscience.org/library/papers/40579133 | PubMed |
| 39795587 | CDC20 and CCNB1 Overexpression as Prognostic Markers in Bladder Cancer. | Diagnostics (Basel) | 2024 | https://conductscience.org/library/papers/39795587 | PubMed |
| 39592474 | Pan-cancer TCGA analysis reveals the potential involvement of B-type lamins in dysregulating chromosome segregation in human cancer. | Mamm Genome | 2025 | https://conductscience.org/library/papers/39592474 | PubMed |
| 39149564 | Evaluating Ovarian Cancer Chemotherapy Response Using Gene Expression Data and Machine Learning. | BioMedInformatics | 2024 | https://conductscience.org/library/papers/39149564 | PubMed |
| 38948050 | CT-based radiomics predicts CD38 expression and indirectly reflects clinical prognosis in epithelial ovarian cancer. | Heliyon | 2024 | https://conductscience.org/library/papers/38948050 | PubMed |
| 38462627 | A gene signature linked to fibroblast differentiation for prognostic prediction of mesothelioma. | Cell Biosci | 2024 | https://conductscience.org/library/papers/38462627 | PubMed |
| 37626693 | Identification of NOX4 as a New Biomarker in Hepatocellular Carcinoma and Its Effect on Sorafenib Therapy. | Biomedicines | 2023 | https://conductscience.org/library/papers/37626693 | PubMed |
| 36923874 | Paxillin is a potential prognostic biomarker associated with immune cell infiltration in ovarian cancer. | Heliyon | 2023 | https://conductscience.org/library/papers/36923874 | PubMed |
| 36915798 | Comprehensive analysis of immune-related genes for classification and immune microenvironment of asthma. | Am J Transl Res | 2023 | https://conductscience.org/library/papers/36915798 | PubMed |
| 36531013 | Role of estrogen receptor signaling pathway-related genes in diffuse large B-cell lymphoma and identification of key targets via integrated bioinformatics analysis and experimental validation. | Front Oncol | 2022 | https://conductscience.org/library/papers/36531013 | PubMed |
Genes3
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| CDC20 | 991 | PubTator's text mining | https://conductscience.org/library/genes/991 | NCBI Gene |
| SOX2 | 6657 | PubTator's text mining | https://conductscience.org/library/genes/6657 | NCBI Gene |
| TP53 | 7157 | PubTator's text mining | https://conductscience.org/library/genes/7157 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/35968331
GET https://conductscience.org/api/papers/v1/35968331/references?page=2